Express Scripts (ESRX) is buying its larger competitor Medco Health Solutions (MHS). Express Scripts is a pharmacy benefit manager. The Wall Street likes the deal and currently Express Scripts is up over $3.00.
Our analysis shows that there may be serious anti trust issues here that the Wall Street has not thought about. Normally we would have given a signal right here, but our long experience with trading Express Scripts stock shows that there is a propensity for a short squeeze. We will not short here, but will watch Express Scripts for a short squeeze. If a short squeeze occurs, we will short this stock at the end of the short squeeze.
An actionable signal will be provided in real-time on the Real Time Feed of the ZYX Short Sell Change Alert.